Esophageal Diseases Global Clinical Trials Review, H2, 2017

2017-08-11
Price :
Published : Aug-2017
No. of Pages : 661
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Esophageal Diseases Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profile Snapshots 38
Appendix 659
Abbreviations 659
Definitions 659
Research Methodology 660
Secondary Research 660
About GlobalData 661
Contact Us 661
Source 661

List of Tables
Esophageal Diseases Therapeutics, Global, Clinical Trials by Region, 2017* 7
Esophageal Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Esophageal Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Esophageal Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Esophageal Diseases Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Esophageal Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Esophageal Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 17
Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 22
Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Esophageal Diseases Therapeutics, Global, Clinical Trials by Phase, 2017* 26
Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
Esophageal Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Esophageal Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Esophageal Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Esophageal Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
Esophageal Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Esophageal Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Esophageal Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures
Esophageal Diseases Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Esophageal Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Esophageal Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Esophageal Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Esophageal Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Esophageal Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Esophageal Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 16
Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 21
Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Esophageal Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
Esophageal Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Esophageal Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Esophageal Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Esophageal Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
Esophageal Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Esophageal Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Esophageal Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
GlobalData Methodology 660
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData